REPORTED PARTICIPANT
ORBIMED ASIA IV MAURITIUS FVCI LIMITED
ORBIMED ASIA IV MAURITIUS FVCI LIMITED: 2 reported NSE/BSE deal sides from 2025-06-11 to 2025-06-11.
Recent disclosures
| Date | Company | Participant | Side | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2025-06-11NSE · Block | Marksans Pharma Limited | ORBIMED ASIA IV MAURITIUS FVCI LIMITED | Sell | 10,273,443 | ₹249.95 | ₹256.78 Cr |
| 2025-06-11NSE · Bulk | Marksans Pharma Limited | ORBIMED ASIA IV MAURITIUS FVCI LIMITED | Sell | 10,273,443 | ₹249.95 | ₹256.78 Cr |